Home >> Life Sciences >> Pharmaceuticals >> General Pharmaceuticals

Global Sports Medicine Market Outlook (2014-2022)

Published: Jun-2015 | Format: PDF | Stratistics MRC | Number of pages: 90 | Code: MRS - 25451

The Global Sports Medicine Market is accounted $31.5 billion in 2014 and is expected to reach $53.6 billion in 2022 at a Compound Annual Growth Rate of 6.8%. Sports medicine is about preventing and treating the athletes and any other people indulged in physical activities from injuries. The Sports Medicine market is the sub set of the orthopedic market. Some of the key factors driving the market are increasing number of cases of sports injuries, gaining popularity of western sports and growing economies to raise the budget allotment for sports. Whereas factors such as lack of trained professionals and cost of certain products are likely to restraint the market growth. Insurance is posing challenge to sports medicine as it would not cover the sports injuries and reimbursement.

The Global Sports Medicine Market is segmented by procedure type, product type, application and geography. By procedure, it is categorized to Cartilage Reconstruction and Repair, Ligament Reconstruction and Repair, Bone Reconstruction & Repair and Surgery. On the basis of product type, it is segmented to orthopedic products and Recovery products. Orthopedic products are sub categorized to Arthroscopy Devices, Fracture Repair Devices, Artificial implants, Orthobiologics and Soft Tissue Fixation Devices. Recovery Products are sub categorized to Braces, Thermotherapy, Performance Monitoring Devices and Accessories. By application, it is segmented to Shoulder, Knee, Hand and Wrist, Elbow, Foot and Ankle, Hip, Groin and Spine. By geography, it is segmented to North America, Europe, Asia Pacific, and Rest of the World.

Some of the key players in the Sports Medicine Market are Arthrex, Biomet Inc., Arthrocare, Conmed Corporation, Stryker Corporation, Otto Bock Healthcare, DJO Global, Zimmer Holdings Inc., Smith & Nephews and Xiros.


  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Content


2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5.1 Cartilage Reconstruction and Repair
5.2 Ligament Reconstruction and Repair
5.3 Bone Reconstruction & Repair
5.4 Surgery

6.1 Orthopedic Products
6.1.1 Arthroscopy Devices
6.1.2 Repair Devices
6.1.3 Artificial implants
6.1.4 Orthobiologics
6.1.5 Soft Tissue Fixation Devices
6.2 Recovery Products
6.2.1 Braces
6.2.2 Thermotherapy
6.2.3 Performance Monitoring Devices
6.2.4 Accessories

7.1 Shoulder
7.2 Knee
7.3 Hand and Wrist
7.4 Elbow
7.5 Foot and Ankle
7.6 Hip
7.7 Groin
7.8 Spine

8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia
8.4 Rest of the World
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10.1 Arthrex
10.2 Biomet Inc.
10.3 Arthrocare
10.4 Conmed Corporation
10.5 Stryker Corporation
10.6 Otto Bock Healthcare
10.7 DJO Global
10.8 Zimmer Holdings Inc.
10.9 Smith & Nephews
10.10 Xiros

Inquiry For Buying

Request Sample

Related Reports

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

Aug-2016 | GBI Research | Pages : 100 | Code : MRS-72180 | 4995

Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion, insulin action, or both. Chronic hyperglycemia in diabetic patients is associated with long-term damage, dysfunction and failure of multiple organs, including the eyes, kidneys, nerves, heart and blood vessels. The vast majority of diabetes mellitus patients can be classified as having either type 1 diabetes mellitus (T1DM) or type 2 diabet Read more

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Aug-2016 | GBI Research | Pages : 66 | Code : MRS-72179 | 6995

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs when a number of aberrant cell signaling events trigger chronic inflammation of the synovium the soft tissue of the joint leading to pain, joint stiffness, and eventually deformity and disability. With the disease affecting 0.31.0% of the global population, the Read more

Global Ophthalmology Drugs Market to 2022-Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

Aug-2016 | GBI Research | Pages : 150 | Code : MRS-72178 | 4995

Ophthalmology is a therapy area that deals with the diagnosis, treatment and prevention of diseases associated with the eyes and visual system. Most eye disorders occur over a long period of time, and are initially asymptomatic or cause only a slight decrease in vision. However, over time this becomes quite marked. Ophthalmologic disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow progressi Read more

Global Gemfibrozil Industry Market Research 2016

Aug-2016 | HJResearch | Pages : 209 | Code : MRS-71776 | 2600

In this report, we analyze the Gemfibrozil industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2011 to 2016. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2011 to 2016. We also make a p Read more

World Kidney/Renal Cancer Drugs Market - Opportunities and Forecasts, 2014 - 2022

Oct-2016 | Allied Market Research | Pages : 0 | Code : MRS-71727 | 4740

Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs. The renal cancer drug therapy market has witnessed a dramatic change in its treatment parad Read more

World Epilepsy Drug Market - Opportunities and Forecasts, 2014 -2022

Oct-2016 | Allied Market Research | Pages : 0 | Code : MRS-71723 | 4740

Epilepsy is a chronic brain disorder characterized by sudden and recurrent episodes of seizure. It is one of the most common neurological disorders worldwide, affecting people of all ages. Presently, around 50 million patients are living with epilepsy worldwide and about 2.4 million new cases are diagnosed annually. Moreover, majority of the epileptic cases are idiopathic, with no identifiable cause. At present, only symptomatic treatment through medication, surgery and implantable devices, Read more

World Hospital Infection Therapeutics Market - Opportunities and Forecasts, 2014 -2022

Oct-2016 | Allied Market Research | Pages : 0 | Code : MRS-71722 | 4740

Hospital acquired infections (HAIs) are one of the leading cause of death across the globe. They are also referred to as nosocomial infections or Healthcare-associated Infections. According to Centers for Disease Control and Prevention (CDC), 1 out of every 25 hospital admitted patient gets contracted with HAIs. Moreover, in the U.S., in 2011, around 75,000 hospitalized patients died from HAIs. The global hospital acquired therapeutics market has observed a significant growth owing to risin Read more

World Mouth Ulcers Treatment Market - Opportunities and Forecasts, 2014 -2022

Oct-2016 | Allied Market Research | Pages : 0 | Code : MRS-71721 | 4740

Mouth ulcers are painful breaks and sores appearing in the mucous membrane of the oral cavity. Increasing use of chemicals in food and oral products such toothpaste, anxiety and stress, and the use of tobacco are some of the factors that may trigger recurrent mouth ulcers. The global mouth ulcer treatment market has observed tremendous growth owing to the growing consciousness for dental and oral hygiene, globally. The presence of moisture and saliva in oral cavity often hinders the topical Read more

World Radiotherapy Equipment Market - Opportunities and Forecasts, 2014 -2022

Oct-2016 | Allied Market Research | Pages : 0 | Code : MRS-71719 | 4740

Radiotherapy or Radiation Therapy is the treatment of cancer using high energy radiation such as X-rays. Radiation therapy is applied to the cancerous area because it has the ability to control the cell growth. The type and amount of radiation a patient receives, is carefully generated, calculated and controlled to damage only the cancer cells, which is accomplished by using various radiotherapy equipment. Recently, newer type of technologies such as image-guided radiation therapy (IGRT) or Read more

World Pediatric Interventional Cardiology Devices Market - Opportunities and Forecasts, 2014 -2022

Oct-2016 | Allied Market Research | Pages : 0 | Code : MRS-71718 | 4740

According to WHO (World Health Organization), an estimated 276,000 babies die within 4 weeks of birth every year, from congenital anomalies. In many countries, congenital anomalies are important causes of childhood death, chronic illness and disability. The rising incidences of congenital anomalies, increasing adoption rate, rising awareness raised the need for pediatric interventional cardiology devices. Recently, with the development of technology, many new types of pediatric intervention Read more

  • Payment Mode
Single User | $(USD)4150 View Pricing